<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00916773</url>
  </required_header>
  <id_info>
    <org_study_id>200712118R</org_study_id>
    <nct_id>NCT00916773</nct_id>
  </id_info>
  <brief_title>Pulmonary Disorders During Exercise in Patients With Obstructive Sleep Apnea</brief_title>
  <official_title>Exercised-Induced Bronchoconstriction in Patients With Severe Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purposes:&#xD;
&#xD;
        1. To investigate whether patients with severe obstructive sleep apnea syndrome (OSAS) are&#xD;
           at higher risk for exercised-induced bronchoconstriction (EIB) due to baseline airway&#xD;
           inflammation compared with age, gender, and body mass index (BMI)-matched controls.&#xD;
&#xD;
        2. To investigate the effect of 3-month continuous positive airway pressure (CPAP) therapy&#xD;
           on EIB for patients with severe OSAS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive sleep apnea syndrome (OSAS) is characterized by repeated episodes of upper airway&#xD;
      obstruction during sleep. Recent studies have found evidence of airway inflammation in&#xD;
      patients with OSAS. Individuals with chronic airway inflammation are at higher risk for&#xD;
      exercise-induced bronchoconstriction (EIB). We hypothesized patients with OSAS are at higher&#xD;
      risk for EIB due to baseline airway inflammation. Continuous positive airway pressure (CPAP)&#xD;
      is a known standard treatment for OSAS, thus the second aim of the study will be&#xD;
      investigating the effect of 3-month CPAP therapy on EIB for patients with OSAS. Twenty severe&#xD;
      OSAS patients and 20 control individuals matched for age, gender, and body mass index (BMI)&#xD;
      will be recruited. All participants will come to the laboratory on 2 separate days (5~14 days&#xD;
      interval). On the 1st visit, baseline pulmonary function test (PFT) and airway inflammation&#xD;
      assess by induced sputum will be performed. On the 2nd visit, an exercise challenge test will&#xD;
      be performed using standard testing protocol and post-exercise forced expiratory volume in&#xD;
      one second (FEV1) will be measured at 2.5, 5, 10, 15,20, and 30 minutes. For patients with&#xD;
      severe OSAS, all measurements will be repeated after 3-month CPAP therapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">April 2010</completion_date>
  <primary_completion_date type="Anticipated">April 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of changed forced expiratory volume in 1 second. (to determine if an exercise-induced bronchoconstriction attacked)</measure>
    <time_frame>3 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of different inflammatory cells in induced sputum. (to determine to severity of baseline airway inflammation)</measure>
    <time_frame>3 month</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <condition>Asthma, Exercise-Induced</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous positive airway pressure (CPAP)</intervention_name>
    <description>CPAP of optimal pressure used during sleep for 3 months</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age ranged 18-65 y/o&#xD;
&#xD;
          2. Severe OSA (AHIâ‰§30/hr)&#xD;
&#xD;
          3. BMI&lt;35 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Clinical asthma&#xD;
&#xD;
          2. Chronic lung disease (FEV1&lt;70% predicted or FEV1/FVC&lt;70%)&#xD;
&#xD;
          3. Exercise contraindication:&#xD;
&#xD;
               -  Stroke or heart attack in last 3 months&#xD;
&#xD;
               -  Major cardiovascular disease&#xD;
&#xD;
               -  Unstable angina&#xD;
&#xD;
               -  Unable to perform cycle ergometry due to musculoskeletal problems&#xD;
&#xD;
          4. Respiratory tract infection in the past 2 weeks&#xD;
&#xD;
          5. Inability to perform acceptable-quality spirometry&#xD;
&#xD;
          6. Refuse to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liying Wang, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>School and Graduate Institute of Physical Therapy, National Taiwan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liying Wang</last_name>
    <phone>886-3366-8123</phone>
    <email>ptschool@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liying Wang, Ph.D.</last_name>
      <phone>+886-2-33668142</phone>
      <email>liying@ntu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <study_first_submitted>June 8, 2009</study_first_submitted>
  <study_first_submitted_qc>June 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2009</study_first_posted>
  <last_update_submitted>June 9, 2009</last_update_submitted>
  <last_update_submitted_qc>June 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>Liying Wang</name_title>
    <organization>School and Graduate Institute of Physical Therapy, National Taiwan University</organization>
  </responsible_party>
  <keyword>Obstructive sleep apnea</keyword>
  <keyword>Airway inflammation</keyword>
  <keyword>Exercise-induced bronchoconstriction</keyword>
  <keyword>Continuous positive airway pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Asthma, Exercise-Induced</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

